BioRestorative Therapies (BRTX) Interest Coverage Ratio Growth (1y) (2011 - 2025)
BioRestorative Therapies (BRTX) Interest Coverage Ratio Growth (1y) (2011 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -60.78% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | -25.59% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 1,170.12% |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 751.68% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 99.48% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | -53.46% |
| 10 | BioRestorative Therapies | 1.94 Mn | -1.02 Mn | 17,964.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 99.73% |
| Jun 30, 2025 | 98.93% |
| Mar 31, 2025 | 73.18% |
| Dec 31, 2024 | 18.90% |
| Sep 30, 2024 | -1,314.76% |
| Jun 30, 2024 | -517.99% |
| Mar 31, 2024 | 76.99% |
| Dec 31, 2023 | 33.21% |
| Sep 30, 2023 | -102.40% |
| Jun 30, 2023 | -74.68% |
| Mar 31, 2023 | -11.02% |
| Dec 31, 2022 | -13.37% |
| Sep 30, 2022 | -1,160.84% |
| Jun 30, 2022 | -1,172.16% |
| Mar 31, 2022 | 67.41% |
| Dec 31, 2021 | -2,904.20% |
| Sep 30, 2021 | 91.74% |
| Jun 30, 2021 | -121.83% |
| Mar 31, 2021 | -16,708.62% |
| Dec 31, 2020 | 48.49% |